Immune pathway mediators

Immune pathway mediators represent a broad and heterogeneous class of endogenous signaling molecules that coordinate the body's immune response and inflammatory processes (StatPearls: Physiology, Inflammation [1]). This category encompasses various proteins including cytokines (such as interleukins and tumor necrosis factors), chemokines, interferons, and intracellular signaling molecules like Janus kinases (JAKs) (NCBI: Cytokines [2]). These mediators act as messengers, facilitating communication between immune cells and regulating the recruitment, activation, and proliferation of leukocytes to defend against pathogens and repair tissue injury [1][2]. In many pathological conditions, such as autoimmune diseases, chronic inflammation, and cancer, the dysregulation or overproduction of these mediators leads to tissue damage or immune evasion (Nature Reviews Immunology [3]). Consequently, many specific molecules within this group serve as critical therapeutic targets for drugs designed to suppress overactive immune responses or enhance anti-tumor immunity (Nature: JAK-STAT signaling [4]).

Other names

Immune mediatorsInflammatory mediatorsImmune signaling moleculesCytokines and chemokinesBiological response modifiers

Modulation of immune signaling through ligand neutralization, competitive receptor blockade, or intracellular signaling enzyme inhibition (NCBI: Cytokines [2], Nature: JAK-STAT [4]).